Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Ingo K MellinghoffPatrick Y Wen

Abstract

Diffuse gliomas are malignant brain tumors that include lower-grade gliomas (LGGs) and glioblastomas. Transformation of low-grade glioma into a higher tumor grade is typically associated with contrast enhancement on magnetic resonance imaging. Mutations in the isocitrate dehydrogenase 1 (IDH1) gene occur in most LGGs (> 70%). Ivosidenib is an inhibitor of mutant IDH1 (mIDH1) under evaluation in patients with solid tumors. We conducted a multicenter, open-label, phase I, dose escalation and expansion study of ivosidenib in patients with mIDH1 solid tumors. Ivosidenib was administered orally daily in 28-day cycles. In 66 patients with advanced gliomas, ivosidenib was well tolerated, with no dose-limiting toxicities reported. The maximum tolerated dose was not reached; 500 mg once per day was selected for the expansion cohort. The grade ≥ 3 adverse event rate was 19.7%; 3% (n = 2) were considered treatment related. In patients with nonenhancing glioma (n = 35), the objective response rate was 2.9%, with 1 partial response. Thirty of 35 patients (85.7%) with nonenhancing glioma achieved stable disease compared with 14 of 31 (45.2%) with enhancing glioma. Median progression-free survival was 13.6 months (95% CI, 9.2 to 33.2 months) ...Continue Reading

References

Jun 1, 1985·Annals of Neurology·J G CairncrossR F DelMaestro
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Apr 1, 2003·Annals of Neurology·Emmanuel MandonnetLaurent Capelle
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Feb 28, 2009·The American Journal of Pathology·Takuya WatanabeHiroko Ohgaki
Jul 29, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc SansonJean-Yves Delattre
Aug 7, 2009·The New England Journal of Medicine·Elaine R MardisTimothy J Ley
Nov 26, 2009·Nature·Lenny DangShinsan M Su
Feb 18, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin J van den BentMarc Sanson
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
Apr 20, 2010·Cancer Cell·Houtan NoushmehrUNKNOWN Cancer Genome Atlas Research Network
Apr 5, 2011·EMBO Reports·Rasheduzzaman ChowdhuryAkane Kawamura
Feb 26, 2014·Journal of Neuro-oncology·Martin ReuterBruce Fischl
Jun 11, 2015·The New England Journal of Medicine·UNKNOWN Cancer Genome Atlas Research NetworkJianan Zhang
Apr 7, 2016·The New England Journal of Medicine·Jan C BucknerWalter J Curran
May 10, 2017·The Lancet Oncology·Michael WellerUNKNOWN European Association for Neuro-Oncology (EANO) Task Force on Gliomas
Jun 8, 2017·Blood·Eytan M SteinMartin S Tallman
Jun 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentSusan M Chang
Apr 25, 2018·Acta Neuropathologica·Mitsuaki ShirahataAndreas von Deimling
Jun 5, 2018·The New England Journal of Medicine·Courtney D DiNardoHagop M Kantarjian
Jul 12, 2018·Journal of Neuro-oncology·Christian F FreyschlagEmmanuel Mandonnet
Jul 3, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Philip JonssonBarry S Taylor
Jul 14, 2019·The Lancet. Gastroenterology & Hepatology·Maeve A LoweryGhassan K Abou-Alfa

❮ Previous
Next ❯

Citations

Sep 29, 2020·Expert Review of Anticancer Therapy·Alessia PellerinoRiccardo Soffietti
Oct 22, 2020·Cancers·Giuseppe LombardiTamara Ius
Oct 8, 2020·Current Opinion in Neurology·Roberta RudàRiccardo Soffietti
Nov 4, 2020·Cancer Discovery·Christopher J Pirozzi, Hai Yan
Jan 6, 2021·International Journal of Molecular Sciences·Alexander OuNazanin Majd
Nov 24, 2020·Cancer Treatment Reviews·Maximilian J MairAnna S Berghoff
Feb 6, 2021·Neuro-oncology Advances·Ashley GhiaseddinStuart A Grossman
Dec 4, 2020·International Journal of Molecular Sciences·Alex HirtzHélène Dumond
Feb 10, 2021·Cancer Discovery·James G Nicholson, Howard A Fine
Nov 10, 2020·Cancer Letters·Tao JiangUNKNOWN Asian Glioma Genome Atlas (AGGA) network
Mar 31, 2021·Neurosurgery Clinics of North America·Matthew A Smith-CohnMark R Gilbert
Feb 25, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Antje WickGhazaleh Tabatabai
Mar 26, 2021·Cancer Research·Yang Liu, Chunzhang Yang
Jun 8, 2021·Molecular Diagnosis & Therapy·Lidia GattoAlba Ariela Brandes
May 28, 2021·Frontiers in Oncology·Erik P Sulman, David D Eisenstat
Jun 17, 2021·Nature Reviews. Clinical Oncology·Christopher J Pirozzi, Hai Yan
Jul 24, 2021·Seminars in Cancer Biology·Gaspar P PintoDavid Bednar
Aug 8, 2021·International Journal of Molecular Sciences·Francesco BrunoRoberta Rudà
Aug 7, 2021·Biomedicines·Alisan KayabolenTugba Bagci-Onder
Jun 4, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ingo K MellinghoffPatrick Y Wen
Aug 24, 2021·Journal of Neuro-oncology·Thomas K SearsKevin D Woolard
Aug 25, 2021·Journal of Experimental & Clinical Cancer Research : CR·Kun YaoHong Tao
Sep 28, 2021·The Cancer Journal·Andrew J ScottDaniel R Wahl
Oct 1, 2021·The Protein Journal·Preantha PoonanMahmoud E S Soliman
Oct 31, 2021·Journal of Hematology & Oncology·Yang XunHua You
Oct 1, 2021·Cold Spring Harbor Molecular Case Studies·Natasha J BrownMichael S Hildebrand
Sep 21, 2021·Anti-cancer Drugs·Caner KaracaGizem Calibasi-Kocal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.